SHAPIRO_STEVE_MD_EVP_20140204_004Steven Shapiro, MD and Alison Morris, MD have been named 2017 Respiratory Health Awardees by the American Thoracic Society (ATS). The Respiratory Health Awards will be presented at several events during the ATS conference. The 2017 American Thoracic Society Conference (ATS) will be held May 19-24 in Washington, DC.

Dr. Shapiro is receiving the Distinguished Achievement Award. The Distinguished Achievement Award is given to individuals who have made outstanding contributions to fighting respiratory disease through research, education, patient care, or advocacy.

Dr. Shapiro leads the Health Services Division as an executive vice president of UPMC, along with his overarching responsibility as chief medical and scientific officer for this integrated delivery and finance system.

In collaboration with the University of Pittsburgh Schools of the Health Sciences and the UPMC Insurance Services Division, Dr. Shapiro is promoting evidence-based care pathways and population health models that position UPMC to provide the highest value and quality to patients.

MORRIS_ALISON_MD_PUL_AI_CC_20130131Dr. Morris is receiving the Recognition Award for Scientific Accomplishments. The Recognition Award for Scientific Accomplishments recognizes outstanding scientific contributions in basic or clinical research to enhance the understanding, prevention and treatment of respiratory disease or critical illness. Awardees are selected based on contributions made throughout their careers or for major contributions made at a particular point in their careers. Awardees will make a 25-minute presentation on their research.

Dr. Morris’ research interests include HIV-associated lung disease as well as the role of the microbiome in disease. Her group works with large cohort epidemiologic studies of HIV and other diseases as well as in translational studies in which physiologic and molecular techniques are applied to patient populations.

As part of her role in the Center for Medicine and the Microbiome, she works with collaborators in diverse areas studying the microbiome. Her clinical interests focus on lung disease in HIV-infected patients and in care of intensive care unit patients.